Feasibility of preoperative and postoperative chemoradiotherapy in gastric adenocarcinoma. Two phase II studies done in parallel. Federation Francophone de Cancerologie Digestive 0308.

Date publication

avril 2014

Auteurs

Membres identifiés du Cancéropôle Est :
Dr JOUVE Jean-Louis

Tous les auteurs :
Michel P, Breysacher G, Mornex F, Seitz JF, Pere-Verge D, Martel-Lafay I, Faroux R, Chapet S, Sobhani I, Pezet D, Aparicio T, Nguyen S, Dousset B, Jouve JL, Maillard E

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/24433843

Résumé

BACKGROUND: For resectable gastric cancer, both postoperative chemoradiotherapy and perioperative chemotherapy demonstrate high-level evidence for improved survival in Western populations. To evaluate the feasibility of pre- or postoperative chemoradiotherapy, we proposed two multicentre phase II studies. PATIENTS AND METHODS: Patients with localised, histologically confirmed gastric cancer and Eastern Cooperative Oncology Group (ECOG) performance status

Référence

Eur J Cancer. 2014 Apr;50(6):1076-83